Mulberroside A - CAS 102841-42-9
Catalog number:
102841-42-9
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C26H32O14
Molecular Weight:
568.52
COA:
Inquire
Targets:
Others
Description:
Mulberroside A, extracted from the root bark of white mulberry, could reduce P-gp expression and function being along with the activation of PKC and NF-κB. It has potential effect in the treatment of prevention of high uric acid and gout disease.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Appearance:
Powder
Synonyms:
3-{(E)-2-[4-(beta-D-glucopyranosyloxy)-2-hydroxyphenyl]ethenyl}-5-hydroxyphenyl beta-D-glucopyranoside
Solubility:
DMSO: 40 mg/mL
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
Mulberroside A, extracted from the root bark of white mulberry, could reduce P-gp expression and function being along with the activation of PKC and NF-κB.
Quality Standard:
Enterprise Standard
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Milligrams-Grams
InChIKey:
HPSWAEGGWLOOKT-VUNDNAJOSA-N
InChI:
InChI=1S/C26H32O14/c27-9-17-19(31)21(33)23(35)25(39-17)37-14-4-3-12(16(30)8-14)2-1-11-5-13(29)7-15(6-11)38-26-24(36)22(34)20(32)18(10-28)40-26/h1-8,17-36H,9-10H2/b2-1+/t17-,18-,19-,20-,21+,22+,23-,24-,25-,26-/m1/s1
Canonical SMILES:
C1=CC(=C(C=C1OC2C(C(C(C(O2)CO)O)O)O)O)C=CC3=CC(=CC(=C3)OC4C(C(C(C(O4)CO)O)O)O)O
1.Down-regulation of P-gp expression and function after Mulberroside A treatment: potential role of protein kinase C and NF-kappa B.
Li Y1, Huang L2, Zeng X1, Zhong G1, Ying M1, Huang M3, Bi H4. Chem Biol Interact. 2014 Apr 25;213:44-50. doi: 10.1016/j.cbi.2014.02.004. Epub 2014 Feb 14.
P-Glycoprotein (P-gp) plays a major role in drug-drug and herb-drug interactions. Mulberroside A (Mul A) is one of the main bioactive constituents of Sangbaipi, the dried root-bark of Morus alba L. (white mulberry), which is officially listed in the Chinese Pharmacopoeia. In the present study, we investigated the effect of Mul A treatment on mRNA expression and protein expression of P-gp in the Caco-2 cells by real-time qPCR and Western blot analysis. The effect of Mul A treatment on the function of P-gp in vitro and in vivo was assessed by Rho123 transport assay and a pharmacokinetic study. The potential roles of protein kinase C (PKC) and nuclear factor kappa B (NF-κB) in the expression regulation of P-gp after Mul A treatment were also investigated. The results revealed that Mul A treatment significantly decreased the mRNA and protein expression of P-gp in Caco-2 cells after treatment with Mul A (5-20 μM). Furthermore, Mul A treatment displayed apparently inhibitory effect on the function of P-gp both in vitro and in vivo.
2.Antihyperlipidemic effects of stilbenoids isolated from Morus alba in rats fed a high-cholesterol diet.
Jo SP1, Kim JK2, Lim YH3. Food Chem Toxicol. 2014 Mar;65:213-8. doi: 10.1016/j.fct.2013.12.040. Epub 2014 Jan 7.
Mulberroside A (MUL) was purified from an ethanol extract of Morus alba root, and oxyresveratrol (OXY) was produced by enzymatic conversion of MUL. Normal rats, Triton WR-1339-induced hyperlipidemic rats, and high-cholesterol diet (HCD)-induced hyperlipidemic rats were orally treated with MUL or OXY (1-5mg/kg/day). MUL and OXY were administered 1h prior to concomitant treatment with Triton WR-1339 for a further 24h, whereas the drugs were administered concurrently with HCD for 4weeks. Oral MUL and OXY pre-treatment vs. water pre-treatment of Triton WR-1339-induced hyperlipidemic rats significantly (p<0.05) reduced the levels of serum lipids in a dose-dependent manner, while high-density lipoprotein cholesterol (HDL-C, or "good" cholesterol) levels were increased. Oral MUL and OXY treatment of HCD-fed rats also showed a significant (p<0.05) dose-dependent decrease in serum lipids, coronary artery risk index (CRI), and atherogenic index (AI), but not HDL-C.
3.[Comparative and correlational studies on contents of stilbenes in different portions of mulberry].
Zhou J1, Li SX2, Yan XP3, Ji M2, Guo XY2, Huang D2, Zheng QY4. Zhongguo Zhong Yao Za Zhi. 2013 Oct;38(19):3261-4.
OBJECTIVE: To compare the contents of stilbenes in different parts and axial root bark of mulberry, and study their correlation.
4.[Quality standard study on Mori Cortex liquid extract].
Liu MF, Xie MP, Li L, Lu AQ, Shi JG, Wang SJ. Zhongguo Zhong Yao Za Zhi. 2015 May;40(10):1850-4.
A reasonable and practicable quality standard was developed for mori liquid extract from different sources by TLC, HPLC and fingerprint technology. In TLC method, the compounds were separated on polyamide film using glacial acetic acid-water (1: 3) as mobile phase at a UV wavelength of 365 nm. All qualified samples had the spots of the same color as the control herb and substance. The RP-HPLC method was used to determine the content of mulberroside A with mobile phase of methanol-water (25: 75) at a wave-length of 326 nm. The mulberroside A was in good linear with a regression equation of Y = 46.965X (r = 0.999 6) in the range of 4.6 - 228 mg x L(-1). In 14 batches of samples, the mulberroside A in 4 batches of them was less than 0.5 g x L(-1), and was more than 2.0 g x L(-1) in the other batches. It was suggested that the content limit of mulberroside A should be no less than 1.5 g x L(-1). The HPLC fingerprints were evaluated by the similarities.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 486-28-2 Fraxinol

Fraxinol
(CAS: 486-28-2)

Fraxinol can be extracted from the bark of Fraxinus chinensis Roxb.

CAS 792957-74-5 ER-000444793

ER-000444793
(CAS: 792957-74-5)

ER-000444793, a potent inhibitor of mitochondrial permeability transition pore (mPTP) opening, inhibits mPTP with an IC50 of 2.8 μM. R-000444793 neither affecte...

PD 142505-0028
(CAS: 161774-09-0)

PD 142505-0028, also know as CI-1017, has been found to be a muscarinic agonist that could exhibit effect against cognition disorder so that was once studied in...

UK-371804
(CAS: 256477-09-5)

UK-371804 is a novel and selective inhibitors of urokinase plasminogen activator (uPA). UK-371804 exhibits excellent enzyme potency (Ki 10 nM) and selectivity p...

CAS 796073-69-3 DM4

DM4
(CAS: 796073-69-3)

DM4, a chemical derivative of maytansine, is an intermediate used to prepare semisynthetic maytansine analogs which can be conjugated with antibodies for the ta...

CAS 79233-15-1 Deoxyandrographolide

Deoxyandrographolide
(CAS: 79233-15-1)

Deoxyandrographolide is a natural compound extracted from the herbs of Andrographis paniculata (Burm. f.) Nees. It could potently inhibit the growth of liver (H...

CAS 149682-77-9 Talabostat

Talabostat
(CAS: 149682-77-9)

Talabostat, also called as PT100 or Val-boroPro, is a potent, nonselective and orally available dipeptidyl peptidase IV(DPP-IV) inhibitor (Ki= 0.18 nM) with ant...

CAS 1323403-33-3 Iberdomide

Iberdomide
(CAS: 1323403-33-3)

Iberdomide, also known as CC-220, is a modulator of cereblon potentially for the treatment of systemic lupus erythematosus. Iberdomide exhibits an IC50 of 60 nM...

CAS 229476-53-3 EBE-A22

EBE-A22
(CAS: 229476-53-3)

The brominated anilinoquinazoline derivative PD153035 exhibits a very high affinity and selectivity for the epidermal growth factor receptor tyrosine kinase (EG...

CAS 22494-42-4 Diflunisal

Diflunisal
(CAS: 22494-42-4)

Diflunisal, a salicylic acid derivative, is a non-steroidal anti-inflammatory drug with analgesic and anti-inflammatory activity.

CAS 465-65-6 Naloxone

Naloxone
(CAS: 465-65-6)

Naloxone is a medication used to block the effects of opioids, especially in overdose useful both in acute opioid overdose and in reducing respiratory or mental...

CAS 522-12-3 Quercitrin

Quercitrin
(CAS: 522-12-3)

Quercitrin is a natural compound extracted from Tartary buckwheat has antiproliferative and apoptotic effects on colon cancer cells.

Desacetylcinobufagin
(CAS: 4026-95-3)

Botanical Source from Bufo bufo gargarizans and Bufo formosus, used for microbial transformation.

CAS 321-64-2 Tacrine

Tacrine
(CAS: 321-64-2)

Tacrine is a centrally acting anticholinesterase and indirect cholinergic agonist for the palliative treatment of mild to moderate dementia of the Alzheimer's t...

CAS 20350-15-6 Brefeldin A

Brefeldin A
(CAS: 20350-15-6)

Brefeldin A is a fungal metabolite and blocks the forward transport between the endoplasmic reticulum and Golgi apparatus, Brefeldin A causes an impaired distri...

CAS 915365-57-0 Cot inhibitor-1

Cot inhibitor-1
(CAS: 915365-57-0)

Cot inhibitor-1 is a COT/Tpl2 inhibitor.

CAS 109552-15-0 Pamidronate disodium pentahydrate

Pamidronate disodium pentahydrate
(CAS: 109552-15-0)

Pamidronate disodium pentahydrate is a nitrogen-containing bisphosphonate, used to prevent osteoporosis.

GYKI-23107 dihydrochloride
(CAS: 83843-39-4)

GYKI-23107 is an antiarrhythmic agent with local anaesthetic activity.

CAS 489416-12-8 ST-193

ST-193
(CAS: 489416-12-8)

ST-193 is a potent, broad-spectrum small-molecule inhibitor of arenavirus entry and exhibits submicromolar antiviral activity in vitro. ST-193 inhibits Guanarit...

CAS 4431-01-0 Ligustilide

Ligustilide
(CAS: 4431-01-0)

Ligustilide not only has an active dilatory effect on myometrium but also an effective role in reducing the neurogenic and inflammatory pain, thus having the po...

Chemical Structure

CAS 102841-42-9 Mulberroside A

Quick Inquiry

Verification code

Featured Items